Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.07% | -61.31% | 2,827.35% | -42.09% | -8.82% |
| Total Depreciation and Amortization | 41.97% | 24.03% | -3.18% | -12.76% | -0.88% |
| Total Amortization of Deferred Charges | 34.81% | -- | -- | -- | 1,264.45% |
| Total Other Non-Cash Items | -3,295.02% | 762.42% | 2,286.30% | 162.28% | -168.86% |
| Change in Net Operating Assets | 342.22% | -978.81% | -1,192.39% | -3,707.33% | -51.34% |
| Cash from Operations | -530.18% | -59.73% | 3,982.45% | -116.90% | -400.20% |
| Capital Expenditure | -1,461.81% | -1,438.54% | -32.93% | -77.09% | 82.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -318.10% | 85.09% | -6,326.65% | 137.87% | 1,215.75% |
| Cash from Investing | -329.92% | 85.03% | -5,354.78% | 138.98% | 2,518.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.44% | -29.57% | -15.92% | -12.45% | 46.85% |
| Issuance of Common Stock | 20,418.52% | -62.82% | -99.62% | -99.76% | -99.45% |
| Repurchase of Common Stock | -- | 72.39% | -310.23% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 82.91% |
| Cash from Financing | 351.95% | 69.43% | -104.84% | -100.04% | -181.44% |
| Foreign Exchange rate Adjustments | 184.83% | 5,865.50% | -18,757.00% | -178.04% | 151.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35,181.24% | 79.66% | 5.18% | -78.24% | -106.59% |